Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology
Cancer cytopathology - United States
doi 10.1002/cncy.21951
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2017
Authors
Publisher
Wiley